The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ELCC 2022 | Impact of COVID-19 on academic research

Name: Impact of COVID-19 on academic research
Uploaded: 2022-03-24T00:00:00Z
Duration: 1 min 15 s
Description: Matthijs Oudkerk, MD, PhD, University of Groningen, Groningen, Netherlands, provides an overview of the impact of the COVID-19 pandemic on lung cancer screening programmes, touching on consequences in the academic research setting and clinical trial develoment. This interview took place during the virtual European Lung Cancer Congress 2022.

Matthijs Oudkerk • 24 Mar 2022

ELCC 2022

Lung Cancer

Matthijs Oudkerk, MD, PhD, University of Groningen, Groningen, Netherlands, provides an overview of the impact of the COVID-19 pandemic on lung cancer screening programmes, touching on consequences in the academic research setting and clinical trial develoment. This interview took place during the virtual European Lung Cancer Congress 2022.